Adaptive Biotechnologies (ADPT) Change in Inventory (2018 - 2026)

Adaptive Biotechnologies has disclosed Change in Inventory across 9 years of filings, most recently posting $1.3 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at $1.3 million, up 598.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 156.95% YoY), and the FY2025 annual result was $998000.0, up 118.58% from the prior year.
• Change in Inventory came in at $1.3 million for Q1 2026 at Adaptive Biotechnologies, up from $10000.0 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $6.6 million in Q1 2023 to a low of -$4.0 million in Q4 2023.
• The 5-year median for Change in Inventory is -$65000.0 (2023), against an average of -$61058.8.
• Peak annual rise in Change in Inventory reached 1358.46% in 2024, while the deepest fall reached 721.61% in 2024.
• Adaptive Biotechnologies' Change in Inventory stood at -$3.0 million in 2022, then slumped by 31.3% to -$4.0 million in 2023, then gained by 14.96% to -$3.4 million in 2024, then jumped by 100.3% to $10000.0 in 2025, then soared by 13050.0% to $1.3 million in 2026.
• The last three Change in Inventory figures came in at $1.3 million (Q1 2026), $10000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.